IP Library Granted Patent US 12,239,335
Granted Patent B2
US 12,239,335 · App. 17/804,244 · Granted Mar 4, 2025

Rotatable connection between an intervention member and a manipulation member of an endovascular device

Inventors: James Davidson (San Juan Capistrano, CA); Andy Huynh (Westminster, CA); Kevin Nguyen (Westminster, CA)
Assignee: Covidien LP
A61B17/221A61B17/22031A61B2017/00243A61B2017/00477A61B2017/12054A61B2017/22034A61B2017/2215
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,335
App. No.
17/804,244
Granted
Mar 4, 2025
Kind
B2
Abstract

A medical device, configured to perform an endovascular therapy, e.g., thrombectomy, can comprise an elongate manipulation member having a first connection member proximate a distal end of the elongate manipulation member, and an intervention member having a second connection member proximate a proximal end of the intervention member. The second connection member can be connected to the first connection member such that the first connection member can rotate relative to the second connection member.

Claims (39)

1. A medical device comprising:

an elongate manipulation member; and

an intervention member comprising an expandable mesh, the intervention member being releasably attached to the elongate manipulation member at a connection, the connection comprising:

a first connection member attached to a distal end portion of the elongate manipulation member, the first connection member comprising a first loop, and

a second connection member attached to a proximal end portion of the intervention member, the second connection member comprising a second loop,

wherein the first connection member and the second connection member are connected indirectly by a third connection member passing through a first opening in the first loop and passing through a second opening in the second loop, and wherein the third connection member is configured to move longitudinally within the first opening and the second opening.

2. The medical device of claim 1 , wherein the elongate manipulation member is tubular.

3. The medical device of claim 1 , wherein the first connection member extends distally away from the elongate manipulation member.

4. The medical device of claim 1 , wherein the third connection member has a different shape than that of the first connection member or the second connection member.

5. The medical device of claim 1 , wherein at least one of the first loop or the second loop has a shape comprising a substantially arcuate section and a substantially straight section.

6. The medical device of claim 1 , wherein the expandable mesh is self-expanding.

7. The medical device of claim 1 , wherein the intervention member is configured to act as an occluding member.

8. The medical device of claim 1 , wherein the expandable mesh defines a plurality of cells.

9. The medical device of claim 1 , wherein the expandable mesh is neither tubular nor cylindrical.

10. The medical device of claim 1 , wherein the first connection member and the elongate manipulation member comprise a single monolithic component and/or the second connection member and the intervention member comprise a single monolithic component.

11. A medical device comprising:

a tubular elongate manipulation member;

a first loop extending distally away from a distal end portion of the tubular elongate manipulation member;

an occluding member comprising a mesh movable between a collapsed state and an expanded state;

a second loop extending proximally away from a proximal end portion of the occluding member; and

an intermediate connection member having a different shape than that of the first loop or the second loop, wherein a proximal portion of the intermediate connection member extends through a first opening of the first loop and a distal portion of the intermediate connection member extends through a second opening of the second loop such that the intermediate connection member connects the first loop to the second loop, and wherein the intermediate connection member is configured to move longitudinally relative to the second loop,

wherein the occluding member is releasably attached to the tubular elongate manipulation member.

12. A method of delivering an intervention member to a bodily lumen of a patient, the method comprising:

distally advancing a medical device through a lumen of a catheter, the medical device comprising:

an elongate manipulation member; and

an intervention member comprising an expandable mesh, the intervention member being releasably attached to the elongate manipulation member at a connection, the connection comprising:

a first connection member attached to a distal end portion of the elongate manipulation member, the first connection member comprising a first loop, and

a second connection member attached to a proximal end portion of the intervention member, the second connection member comprising a second loop,

wherein the first connection member and the second connection member are connected indirectly by a third connection member passing through a first opening in the first loop and passing through a second opening in the second loop, and wherein the third connection member is configured to move longitudinally within the first opening and the second opening,

releasing the intervention member from the lumen of the catheter such that the intervention member expands from a collapsed configuration to an expanded configuration;

detaching the intervention member from the elongate manipulation member; and

withdrawing the catheter and the elongate manipulation member from the bodily lumen while the intervention member remains within the bodily lumen.

13. The method of claim 12 , wherein distally advancing the medical device comprising distally advancing the elongate manipulation member.

14. The method of claim 12 , wherein the intervention member is positioned distal of the distal end portion of the elongate manipulation member while distally advancing the medical device through the lumen of the catheter.

15. The method of claim 12 , wherein the elongate manipulation member is tubular.

16. The method of claim 12 , wherein the intervention member comprises an occluding member.

17. The method of claim 12 , wherein the bodily lumen is a blood vessel.

18. The method of claim 12 , wherein releasing the intervention member from the lumen of the catheter such that the intervention member expands from the collapsed configuration to the expanded configuration comprises causing the intervention member to engage a wall of the bodily lumen.

19. The method of claim 12 , wherein the third connection member has a different shape than that of the first connection member or the second connection member.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2022
From: DAVIDSON, JAMES; HUYNH, ANDY; NGUYEN, KEVIN
To: COVIDIEN LP
Reel/Frame 060048/0170 →
Continuity (3)
Continuation 16709431 · Dec 10, 2019
Continuation 14921223 · Oct 23, 2015
Related Publication 20220280176A1 · Sep 8, 2022
References Cited (105)
US 7300458B2 · Henkes et al. · 2007 [cited by applicant]
US 7306618B2 · Demond et al. · 2007 [cited by applicant]
US 7648518B2 · Salahieh et al. · 2010 [cited by applicant]
US 8092508B2 · Leynov et al. · 2012 [cited by applicant]
US 8603014B2 · Alleman et al. · 2013 [cited by applicant]
US 8777978B2 · Strauss et al. · 2014 [cited by applicant]
US 8837800B1 · Bammer et al. · 2014 [cited by applicant]
US 8968383B1 · Johnson et al. · 2015 [cited by applicant]
US 9119656B2 · Bose et al. · 2015 [cited by applicant]
US 9126018B1 · Garrison · 2015 [cited by applicant]
US 9211132B2 · Bowman · 2015 [cited by applicant]
US 9241699B1 · Kume et al. · 2016 [cited by applicant]
US 9265512B2 · Garrison et al. · 2016 [cited by applicant]
US 9308007B2 · Cully et al. · 2016 [cited by applicant]
US 9399118B2 · Kume et al. · 2016 [cited by applicant]
US 9445828B2 · Turjman et al. · 2016 [cited by applicant]
US 9445829B2 · Brady et al. · 2016 [cited by applicant]
US 9492637B2 · Garrison et al. · 2016 [cited by applicant]
US 9539022B2 · Bowman · 2017 [cited by applicant]
US 9561345B2 · Garrison et al. · 2017 [cited by applicant]
US 9579119B2 · Cully et al. · 2017 [cited by applicant]
US 9585741B2 · Ma · 2017 [cited by applicant]
US 9642635B2 · Vale et al. · 2017 [cited by applicant]
US 9655633B2 · Leynov et al. · 2017 [cited by applicant]
US 9737318B2 · Monstadt et al. · 2017 [cited by applicant]
US 9770251B2 · Bowman et al. · 2017 [cited by applicant]
US 9801643B2 · Hansen et al. · 2017 [cited by applicant]
US 9861783B2 · Garrison et al. · 2018 [cited by applicant]
US 9993257B2 · Losordo et al. · 2018 [cited by applicant]
US 10028782B2 · Orion · 2018 [cited by applicant]
US 10029008B2 · Creighton · 2018 [cited by applicant]
US 10039906B2 · Kume et al. · 2018 [cited by applicant]
US 20010018596A1 · Selmon et al. · 2001 [cited by applicant]
US 20070162048A1 · Quinn et al. · 2007 [cited by applicant]
US 20080188886A1 · Kusleika et al. · 2008 [cited by applicant]
US 20090082800A1 · Janardhan · 2009 [cited by applicant]
US 20100137898A1 · Teoh · 2010 [cited by applicant]
US 20110004238A1 · Palmer et al. · 2011 [cited by applicant]
US 20110060212A1 · Slee et al. · 2011 [cited by applicant]
US 20110160763A1 · Ferrera et al. · 2011 [cited by applicant]
US 20120071916A1 · Kusleika et al. · 2012 [cited by applicant]
US 20120083868A1 · Shrivastava et al. · 2012 [cited by applicant]
US 20120172920A1 · Fifer et al. · 2012 [cited by applicant]
US 20130030461A1 · Marks et al. · 2013 [cited by applicant]
US 20130281788A1 · Garrison · 2013 [cited by applicant]
US 20130345739A1 · Brady et al. · 2013 [cited by applicant]
US 20140194911A1 · Johnson et al. · 2014 [cited by applicant]
US 20140194919A1 · Losordo et al. · 2014 [cited by applicant]
US 20140276074A1 · Warner · 2014 [cited by applicant]
US 20140343595A1 · Monstadt et al. · 2014 [cited by applicant]
US 20150039017A1 · Cragg et al. · 2015 [cited by applicant]
US 20150080937A1 · Davidson · 2015 [cited by applicant]
US 20150100113A1 · Davidson et al. · 2015 [cited by applicant]
US 20150133990A1 · Davidson · 2015 [cited by applicant]
US 20150359547A1 · Vale et al. · 2015 [cited by applicant]
US 20160015402A1 · Brady et al. · 2016 [cited by applicant]
US 20160015935A1 · Chan et al. · 2016 [cited by applicant]
US 20160030047A1 · Allen et al. · 2016 [cited by applicant]
US 20160106448A1 · Brady et al. · 2016 [cited by applicant]
US 20160106449A1 · Brady et al. · 2016 [cited by applicant]
US 20160113663A1 · Brady et al. · 2016 [cited by applicant]
US 20160113665A1 · Brady et al. · 2016 [cited by applicant]
US 20160151618A1 · Powers et al. · 2016 [cited by applicant]
US 20160157985A1 · Vo et al. · 2016 [cited by applicant]
US 20160199620A1 · Pokorney et al. · 2016 [cited by applicant]
US 20160296690A1 · Kume et al. · 2016 [cited by applicant]
US 20160302808A1 · Loganathan et al. · 2016 [cited by applicant]
US 20160375180A1 · Anzai · 2016 [cited by applicant]
US 20170079766A1 · Wang et al. · 2017 [cited by applicant]
US 20170079767A1 · Leon-Yip · 2017 [cited by applicant]
US 20170086862A1 · Vale et al. · 2017 [cited by applicant]
US 20170100143A1 · Grandfield · 2017 [cited by applicant]
US 20170105743A1 · Vale et al. · 2017 [cited by applicant]
US 20170164963A1 · Goyal · 2017 [cited by applicant]
US 20170215902A1 · Leynov et al. · 2017 [cited by applicant]
US 20170224953A1 · Tran et al. · 2017 [cited by applicant]
US 20170281909A1 · Northrop et al. · 2017 [cited by applicant]
US 20170290599A1 · Youn et al. · 2017 [cited by applicant]
US 20180049762A1 · Seip et al. · 2018 [cited by applicant]
US 20180084982A1 · Yamashita et al. · 2018 [cited by applicant]
US 20180116717A1 · Taff et al. · 2018 [cited by applicant]
US 20180132876A1 · Zaidat · 2018 [cited by applicant]
US 20180140314A1 · Goyal et al. · 2018 [cited by applicant]
US 20180140315A1 · Bowman et al. · 2018 [cited by applicant]
US 20180140354A1 · Lam et al. · 2018 [cited by applicant]
US 20180185614A1 · Garrison et al. · 2018 [cited by applicant]
US 20200113590A1 · Davidson et al. · 2020 [cited by applicant]
EP 1346703A1 · 2003 [cited by applicant]
EP 2319575B1 · 2013 [cited by applicant]
JP 2014004219A · 2014 [cited by applicant]
JP 2018118132A · 2018 [cited by applicant]
KR 20180102877A · 2018 [cited by applicant]
WO 2014109840A1 · 2014 [cited by applicant]
WO 2015141317A1 · 2015 [cited by applicant]
WO 2017192999A1 · 2017 [cited by applicant]
WO 2018019829A1 · 2018 [cited by applicant]
WO 2018033401A1 · 2018 [cited by applicant]
WO 2018046408A2 · 2018 [cited by applicant]
WO 2018137029A1 · 2018 [cited by applicant]
WO 2018137030A1 · 2018 [cited by applicant]
WO 2018145212A1 · 2018 [cited by applicant]
WO 2018156813A1 · 2018 [cited by applicant]
WO 2018172891A1 · 2018 [cited by applicant]
WO 2018187776A1 · 2018 [cited by applicant]
International Search Report and Written Opinion mailed Dec. 16, 2016; International Application No. PCT/US2016/057864; 12 pages. [cited by applicant]